Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
FATE
FATE THERAPEUTICS INC
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$2.37
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$283.97M
Country
USA
RECENT INSIDER TRADES
2026-08-05
· Valamehr Bahram
(President and CEO)
· SELL
2026-08-05
· TAHL CINDY
(See Remarks)
· SELL
2026-05-21
· TAHL CINDY
(See Remarks)
· SELL
2026-05-21
· Valamehr Bahram
(President and CEO)
· SELL
2026-05-07
· TAHL CINDY
(See Remarks)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
165
Shares held
97,823,253
Value
$239.44M
Percent of shares outstanding
81.64%
As of quarter end
2026-06-30
RECENT NEWS
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Fate Therapeutics to participate in fourth quarter 2026 conferences
Fate Therapeutics receives $15m CIRM grant for lupus trial
Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN
Fate Therapeutics selected for four presentations at ACR Convergence 2026
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS